LAWYER PROFILE
Tina Tai

Tina Tai

Greater China Region 2026

Chambers ranking badge
Chambers ranking badge

Ranked in 1 practice area

About

Provided by King & Wood

Greater China Region

Practice Areas

Ms. Tai has more than 27 years' experience as an IP practitioner, and worked with one of China's largest IP firms for long time as the executive member before joining KWM.

Ms. Tai is one of the most influential figures in IP law in the pharmaceutical and healthcare sectors, and has represented many influential cases including the Viagra® (Sildenafil) and Lipitor® (Atrovastatin) for Pfizer, Brillinta® (Ticagrelor) for AstraZeneca, Xarelto® (Rivaroxaban) for Bayer, Actemra® (Tocilizumab) for Roche/Chugai, Victoza® (Liraglutide) for Novo Nordisk, Entresto® (Valsartan Sacubitril) and Revolade® (Eltrombopag) for Novartis, in the patent invalidation and infringement litigations.

Ms. Tai is well experienced with the communication with the courts and government authorities including CNIPA and NMPA for patent and drug regulatory issues.

Chambers Review

Provided by Chambers

Chambers Greater China Region

Intellectual Property: Litigation (PRC Firms) - China

Band 1
Band 1

Individual Editorial

Tina Tai is a market veteran with three decades of experience in the IP space. Her expertise in patent invalidation matters is in high demand among pharmaceutical and healthcare companies.

领先律师
邰红律师是一位在知识产权领域拥有近三十年的经验的资深律师。她在专利无效事宜上的专业知识受到了制药和医疗公司中的热捧。

Strengths

Provided by Chambers

  • I am very satisfied with Tina in the invalidation and litigation proceedings. Her team is the top one in the industry.

    Intellectual Property: Litigation (PRC Firms)Chambers Greater China Region
  • 我对邰红律师在无效和诉讼程序中的表现非常满意。她的团队是业内顶尖的。

    Intellectual Property: Litigation (PRC Firms)Chambers Greater China Region

Ranked Individuals at King & Wood (145)

China

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership